6-108323896-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_145315.5(AFG1L):c.211G>A(p.Val71Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000134 in 1,614,120 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_145315.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
AFG1L | NM_145315.5 | c.211G>A | p.Val71Ile | missense_variant | 2/13 | ENST00000368977.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
AFG1L | ENST00000368977.9 | c.211G>A | p.Val71Ile | missense_variant | 2/13 | 1 | NM_145315.5 | P1 | |
AFG1L | ENST00000437715.1 | c.112G>A | p.Val38Ile | missense_variant | 3/6 | 5 | |||
AFG1L | ENST00000421954.5 | c.18+28678G>A | intron_variant | 5 | |||||
AFG1L | ENST00000430458.1 | n.300G>A | non_coding_transcript_exon_variant | 2/4 | 5 |
Frequencies
GnomAD3 genomes AF: 0.000145 AC: 22AN: 152134Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000251 AC: 63AN: 251466Hom.: 1 AF XY: 0.000302 AC XY: 41AN XY: 135900
GnomAD4 exome AF: 0.000133 AC: 194AN: 1461868Hom.: 1 Cov.: 31 AF XY: 0.000149 AC XY: 108AN XY: 727238
GnomAD4 genome AF: 0.000144 AC: 22AN: 152252Hom.: 0 Cov.: 32 AF XY: 0.000134 AC XY: 10AN XY: 74462
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 13, 2023 | The c.211G>A (p.V71I) alteration is located in exon 2 (coding exon 2) of the LACE1 gene. This alteration results from a G to A substitution at nucleotide position 211, causing the valine (V) at amino acid position 71 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at